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The Amsacta moorei entomopoxvirus (AmEPV) spheroidin is the most highly expressed late viral gene product in infected
insect cells. However, when a cassette containing the spheroidin gene and putative promoter was inserted into cowpox
(CPV) or vaccinia viruses, only very low levels of spheroidin gene expression were observed. Primer extension analysis
suggests much lower spheroidin gene transcript levels than seen either for the highly expressed CPV A-type inclusion gene
or for the spheroidin gene within infected insect cells, indicating that in vertebrate cells, the spheroidin promoter functions
poorly if at all. Examination of the spheroidin mRNA synthesized in recombinant CPV shows that the 5* start site of the
spheroidin transcript was also unexpectedly imprecise and upstream (approximately 31 bp) of the well-defined start site
normally observed in AmEPV-infected insect cells. Sequencing of the 5* terminus of the CPV recombinant spheroidin mRNA
suggested that 5* poly(A), a characteristic feature of late poxvirus mRNAs and spheroidin mRNA derived from insect cells,
was absent, despite the presence of the typical vertebrate poxvirus late promoter consensus sequence, TAAATG. Our
results indicate that insect and vertebrate poxvirus promoters may not be universally interchangeable and imply that there
are regulatory features of gene expression unique to the infected insect cell environment. q 1996 Academic Press, Inc.
INTRODUCTION are not recognized by eukaryotic RNA polymerase II
(Puckett and Moss, 1983). There are conserved motifs in
The molecular biology of entomopoxviruses, poxvi-
each temporal class of promoter. The requirements for
ruses of insects, has been recently reviewed (Arif, 1995).
late promoters have been extensively analyzed by Davi-Because a number of vertebrate poxvirus gene homologs
son and Moss (1989). Poxvirus promoters, when removedhave been found in entomopoxviruses (Hall and Moyer,
from their normal context and fused to foreign genes,1991; Mustafa and Yuen, 1991; Yuen et al., 1991), it is
retain their predicted regulatory pattern and level of ex-reasonable to expect similarities in gene expression and
pression (Puckett and Moss, 1983; Mackett et al., 1984).promoter function.
Evidence to date suggests that among poxviruses, pro-Gene expression in the vertebrate poxviruses is tem-
moters are generally interchangeable. Fowlpox virus canporally regulated (early, intermediate, and late). Little is
use the vaccinia p11 and p7.5 promoters, and the cowpoxknown about the patterns of transcription in entomopox-
A-type inclusion (ATI) promoter (Boyle, 1992; Kumar andviruses, but it is assumed to be of a similar nature. Verte-
Boyle, 1990; Prideaux et al., 1990). Data obtained for thebrate poxvirus late genes are regulated by promoters
entomopoxvirus fusolin gene are also consistent withwhich generally contain a conserved TAAATG transcrip-
this hypothesis (Gauthier et al., 1995; Pearson et al.,tion/translation initiation motif (Ha¨nggi et al., 1986; Rosel
1991). When a plasmid containing the Melolontha melo-et al., 1986) and produce mRNAs which contain a 5* cap
lontha entomopoxvirus fusolin gene, containing nativeand 5* and 3* poly(A) sequences (Ahn and Moss, 1989;
upstream and downstream regulatory elements, wasPatel and Pickup, 1987; Schwer et al., 1987; Schwer and
transfected into vaccinia-infected mammalian cells, tran-Stunnenberg, 1988; Wright and Moss, 1987). Transcrip-
sient expression of fusolin resulted (Gauthier et al., 1995).tion generally initiates at one of the As within the TAAATG
The Choristoneura biennis entomopoxvirus fusolin pro-motif (Davison and Moss, 1989). Late mRNAs are hetero-
moter appeared to function efficiently when fused to thegeneous in length, as discrete termination is lacking
lacZ gene (Pearson et al., 1991). In comparison to a vac-(Bertholet et al., 1987).
cinia p7.5 promoter– lacZ fusion, the fusolin– lacZ recom-Poxvirus promoters are unique in the sense that they
binant produced about five times greater enzyme activity.
It is also interesting to note that the 5* untranslated re-
1 Current address: Department of Medicine, University of Florida, gion of the fusolin gene and that of the vaccinia majorPost Office Box 100277, Gainesville, Florida 32610-0277.
core protein precursor, p4b, exhibit significant homology2 To whom correspondence and reprint requests should be ad-
dressed. Fax: (352) 392-3133. (Yuen et al., 1990).
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Some differences between entomopoxvirus and vac- were used to create recombinant vertebrate poxviruses
containing the spheroidin cassette. Plasmid pHGN3.1cinia promoters are suggested, however, since another
recombinant with nucleotides 01 to 020 of the fusolin (Fig. 1), which contains the VV hemagglutinin (HA) coding
region interrupted with a multiple cloning site, has beenpromoter deleted produced as much enzyme activity as
the recombinant with the intact fusolin promoter driving described (Bloom et al., 1991). Plasmid pHGN4.1 (Fig. 1)
was derived from pHGN3.1 by inserting a vaccinia p7.5lacZ expression. The fusolin promoter contains the pro-
moter sequence TAATG instead of the more common promoter-driven Escherichia coli gpt gene (Ecogpt) (in
opposite orientation to the HA gene, i.e., antiparallel) intoTAAATG (Pearson et al., 1991).
One of the most highly expressed vertebrate poxvirus EcoRV-cut pHGN3.1. All plasmids described below are
summarized schematically in Fig. 1.genes is the cowpox virus ATI gene (Patel and Pickup,
1987; Patel et al., 1988), and the most highly expressed Plasmid pRH7 (Fig. 1) (6.073 kb), ATCC 68902, contains
the AmEPV spheroidin cassette. The spheroidin cassetteentomopoxvirus gene is that encoding spheroidin (Hall
and Moyer, 1991). As for the ATI gene, the spheroidin consists of 306 bp of upstream and 92 bp of sequence
following the spheroidin translation termination codongene is nonessential in infection of cell cultures and may
be deleted with no detrimental effect on the virus (Palmer (DNA from bp 2774 to 6183 of GenBank locus AAV-
SPHERE). It was prepared by cloning a T4 DNA polymer-et al., 1995). It would be generally expected, because
of the presence of a 5* poly(A) on the entomopoxvirus ase-blunted HaeII– Bsp1286 I fragment (of genomic
AmEPV DNA) into SmaI-digested pUC9.spheroidin mRNA and a typical TAAATG consensus se-
quence at the transcription initiation site (Hall and Moyer, Plasmid pRH243 (Fig. 1) (9.6 kb), is derived from
EcoRI–BamHI-digested pHGN3.1 into which was in-1991; Sanz et al., 1994), that the ATI and spheroidin genes
of the vertebrate and invertebrate poxviruses, respec- serted the EcoRI–BamHI fragment of pRH7 (containing
the spheroidin cassette). This created a transfer vectortively, would be expressed and regulated in a similar
fashion. for inserting the spheroidin cassette into the HA gene in
which the relative direction of transcription of both genesWe have examined the transcription of the spheroidin
gene, both within the native context of Amsacta moorei is in an antiparallel orientation.
Plasmid pRH261 (Fig. 1) (9.8 kb), contains an EcoRI –entomopoxvirus (AmEPV)-infected insect cells and within
vertebrate cells infected with vaccinia or cowpox virus NotI fragment (containing the spheroidin cassette) in-
serted into EcoRI–NotI-digested pHGN4.1. Transfectionrecombinants containing the spheroidin gene. Despite
being the most highly expressed gene within AmEPV- of vaccinia/cowpox virus-infected cells yields recombi-
nants where the spheroidin gene and the HA gene areinfected insect cells, very little spheroidin protein was
synthesized when the spheroidin gene was inserted into in an antiparallel orientation to each other.
Plasmid pRH300 (Fig. 1) (9.6 kb), is a HindIII– EcoRI-the genome of either vaccinia or cowpox virus. We have
concluded that this is due, at least in part, to improper digested pHGN3.1 into which was inserted the HindIII –
EcoRI fragment of pRH7 (containing the spheroidin cas-spheroidin gene transcription within the vertebrate envi-
ronment. sette). This created a transfer vector where the spher-
oidin gene is inserted into vaccinia or cowpox virus
within the HA gene where the transcription of both genesMATERIALS AND METHODS
relative to each other is in the same direction. This plas-
Viruses and cell culture mid was used to construct a recombinant cowpox virus,
vRH300, by homologous recombination.AmEPV (Hall and Moyer, 1991) was propagated in
Plasmid pRH433 (Fig. 1) (6.7 kb), is similar to pRH7IPLB-LD-652 cells (Goodwin et al., 1990) maintained at
except it contains 677 bp downstream of the terminating267 in a 50:50 mixture of EX-CELL 401 media (EX-CELL)
codon of spheroidin rather than 92 bp as in pRH7. Plas-(JRH Biosciences, Lenexa, KS) and TC-100 media (Gibco,
mid pRH433 was created by inserting the 1.8-kb EcoRI –Gaithersburg, MD), supplemented with 10% fetal bovine
PacI fragment of pRH87 (Hall and Moyer, 1991), whichserum (FBS), 50 U of penicillin/ml, and 50 mg of strepto-
contains the longer 3* spheroidin flanking sequence, intomycin/ml. Vaccinia virus (VV) strain WR (Condit and Mo-
the 4.9-kb EcoRI–PacI fragment of pRH7. This resultanttyczka, 1981) and cowpox virus, Brighton red strain, were
plasmid contains a spheroidin cassette with the longerproduced at 377 in CV-1, RK-13, or BSC40 cells, cultured
3* downstream flanking sequence.in Eagle’s minimal essential media with Earle’s salts sup-
Plasmid pDU20lacZ (Fig. 1) was used to construct aplemented with 5% FBS, 50 U of penicillin/ml, and 50 mg
spheroidin-negative recombinant AmEPV in which a lacZof streptomycin/ml.
open reading frame regulated by the spheroidin promoter
plus 20 bp of additional sequence downstream from thePlasmid constructions
starting ATG was inserted into the spheroidin gene. To
construct pDU20lacZ, oligonucleotide primers RM316Plasmids containing the vaccinia virus hemagglutinin
gene—into which was inserted a spheroidin cassette— and RM315 were first used in a polymerase chain reac-
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FIG. 1. Plasmid constructs. The overall structure of the inserts in the plasmids described under Materials and Methods are diagrammatically
presented here (not shown drawn to scale). The direction of gene transcription is shown by arrows. Plasmid designations are shown at the left of
the diagrams. The promoter in the promoter– lacZ plasmids may be the vaccinia p11 or p7.5, the cowpox ATI, or the AmEPV spheroidin promoter.
Abbreviations are as follows: Eco gpt, a vaccinia p7.5 promoter-driven E. coli gpt gene cassette; HA, vaccinia hemagglutinin gene; lacZ, promoterless
E. coli lacZ gene; MCS, multiple cloning site; SPH, AmEPV spheroidin gene; TK, rabbitpox virus thymidine kinase gene; and X, any of the four above-
listed promoters.
tion (PCR) with a spheroidin promoter-containing plas- (5.0 kb). PDU20 was cut with BamHI and a lacZ gene
with BamHI ends (from plasmid pMC1871, Pharmaciamid, pRH512 (Hall and Moyer, 1991), template. The PCR
conditions were 30 cycles of 947 for 1 min, 457 for 1 min, Biotech, Piscataway, NJ) was inserted to produce pDU20-
lacZ.727 for 1 min, and subsequently 727 for 8 min to complete
the extensions. RM316 was from bp 2056 to 2075 of A series of different poxvirus promoter – lacZ fusion
(promoter – lacZ) cassettes (Fig. 1) were constructedGenBank locus AAVSPHERE and had the sequence ACA-
GGAGCTCGCTATTATAACTAATGTGAG. RM315 was to study the promoter activity using the in-frame re-
porter gene. Promoter– lacZ fusion plasmids (designatedfrom bp 3102 to 3083 of GenBank locus AAVSPHERE and
had the sequence CACAGGATCCGTTGCTAAAGGTAC- pXlacZ in Fig. 1, where ‘‘X’’ refers to the promoter) were
prepared for the following three promoters: vaccinia p7.5,GTTACT. Collectively, these two primers produced a
1046-bp fragment which had a 5* SacI site and a 3* cowpox ATI, and AmEPV spheroidin. Also used in this
study was a fourth promoter– lacZ fusion, one involvingBamHI site. This fragment contained 1023 bp of upstream
spheroidin sequence, plus the starting ATG of the spher- the vaccinia p11 derived directly from plasmid pSC11
previously used to form a stable recombinant vacciniaoidin coding sequence. Twenty base pairs of spheroidin
coding sequence then follow the starting ATG. In a sepa- virus, vSC8 (Chakrabarti et al., 1985). The first step in
the construction of the promoter– lacZ cassettes was torate PCR reaction, oligonucleotide primers RM313 and
RM314 were used to amplify a 998-bp fragment of spher- subclone the E. coli lacZ gene such that it lacked a pro-
moter and an ATG translational start codon. The plasmidoidin coding sequence using pRH7 as a template. RM313
was from bp 4357 to 4376 of GenBank locus AAVSPHERE pSC11, which contains the lacZ gene without the first 10
codons, was cut with XhoI and PstI to remove the desiredand had the sequence AGAGAAGCTTCAGCCCAGATA-
CTACGATTC. RM314 was from bp 5355 to 5336 of Gen- 3072-bp fragment. This truncated lacZ gene was ligated
into XhoI–PstI-cut pBluescript I (KS/) to give pBS-lacZ.Bank locus AAVSPHERE and had the sequence CAC-
AGTTAACACACTTGATGCAACTCTAGC. This PCR-pro- This intermediate plasmid was used to generate the
three promoter fusions. Digestion of this plasmid withduced fragment contains a 5* HindIII and a 3* HincII site.
These two PCR products were separately cloned into the KpnI linearizes pBS-lacZ just upstream of the inserted
lacZ gene. The poxvirus promoters were each PCR ampli-SacI–BamHI site and the HindIII– HincII site of pBlue-
script I (SK/) to produce an intermediate vector, pDU20 fied using the following primer pairs and appropriate viral
AID VY 8176 / 6A20$$$162 09-14-96 09:19:50 vira AP: Virology
430 HALL ET AL.
DNA template. For the vaccinia p7.5 promoter, RM177 hours postinfection (p.i.), the inoculum was aspirated and
1 ml of the diluted transfection mix was added. The con-(CTCGGTACCGACATATACTATATAGTAATACC) and RM178
(GGACGATATATTGTTTCTCGAGAACATGATTGCTATTG) centrated transfection mix was prepared by separately
combining 20 ml Lipofectin (Gibco, Gaithersburg, MD)amplified a 316-bp fragment, of which 280 bp were poxvi-
rus DNA. For the cowpox virus ATI promoter, RM210 and 80 ml of a 50:50 mix of EX-CELL and TC-100 media
without FBS (50:50 media), and 5 mg of pDU20lacZ plas-(CTCGGTACCCTTGATAATCATATATTAAACACATTGG)
and RM211 (CGTGACCTCCTCGAGAACATTTATTATAAA- mid in a volume of 100 ml of the same media. This was
allowed to complex at room temperature for 15 min. ThisAAAATTTTATTC) amplified a 314-bp fragment, of which
288 bp were poxvirus DNA. For the AmEPV spheroidin concentrated transfection mix was diluted by adding 800
ml of the 50:50 media without FBS. After 6 hr, the transfec-promoter, RM204 (CTCGGTACCATATTTTATGCAGTT-
TCAACTTTTGG) and RM205 (CCTTTCTCGAGAACATTT- tion mix was removed and replaced with 2 ml of 50:50
media with 10% FBS. The infection was continued for 3ATTATTATTAATATATAAAAAATAAAAAGTCC) amplified
a 309-bp fragment of which 287 bp were poxvirus DNA. days and the supernatant was harvested by centrifuga-
tion at 200 g. Dilutions at 1002 to 1004 of the supernatantFor each amplified promoter region, the upstream primer
included a KpnI site and the downstream primer con- were made and used to infect cells in six-well plates.
After 2 hr, the supernatant was aspirated. The cells weretained the starting ATG, a 2-base insertion to correct the
reading frame, and an XhoI site. The PCR products were overlaid with 2 ml of 1% SeaPlaque agarose prepared in
TC-100 media supplemented with 10% FBS, equilibratedcut with KpnI and XhoI and individually inserted into lin-
earized pBS-lacZ to produce the promoter– lacZ fusions. to 407, to which X-gal had been added to a final concen-
tration of 120 mg/ml. The 1% agarose overlay was pre-The promoter areas were sequenced to verify the ab-
sence of PCR-generated errors. To create stable vaccinia pared by combining appropriate amounts of autoclaved,
407C-equilibrated 4% agarose, prepared in water, andvirus recombinants containing each of the promoter –
lacZ cassettes individually inserted into the thymidine 407C-equilibrated 1.331 TC-100 media. A 1.331 solution
of TC-100 media was prepared by using powered media,kinase (TK) gene, transfer vectors were constructed by
subcloning the KpnI– PstI fragment into a plasmid, adjusting to pH 6.2 with a 5 M potassium hydroxide solu-
tion, and sterile filtering. Plates were examined for bluepRPVTK-MCS, which contained a multiple cloning site
inserted within a cloned rabbitpox virus (RPV) TK gene. plaques after 4 or 5 days. Plaques were picked with a
Pasteur pipette and placed in 1 ml of TC-100 media plusPlasmid pRPVTK-MCS was made by inserting the 1.76-
kb HindIII/XhoI fragment from the left end of the RPV 10% FBS and stored overnight at 47. The tube was vor-
texed and dilutions of 1001 to 1003 were made. PlaquesHindIII J fragment, which contains the TK gene, into
pBluescript. A polylinker was inserted into the single were purified four times. Recombinant virus was stored
at 47 for 2 or 3 months or at 0707 for long-term storage.EcoRI site in the TK gene. The promoter– lacZ cassettes
were inserted in an antiparallel orientation to the RPV TK
SDS–PAGE, Western blot, antibody probing, andgene promoter. The stable vaccinia recombinants were
protein preparationselected using BUdR and standard techniques (Smith
and Moss, 1984).
Protein electrophoresis using 10% separating gels, im-
munoblotting, and protein preparation were as describedAnti-spheroidin sera preparation
previously (Hall and Moyer, 1993).
The antigen was prepared by solubilizing AmEPV oc-
Preparation of vertebrate poxvirus recombinantsclusion bodies in Laemmli sample buffer (Hall and
containing the intact spheroidin gene cassetteMoyer, 1993) and running preparatory sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS –
Four vertebrate poxvirus recombinants containing the
PAGE) gels. The spheroidin (115-kDa) band was excised
spheroidin cassette inserted into the HA gene were con-
and directly emulsified in Ribi’s adjuvant (Ribi Immuno-
structed by use of transfection of appropriate transfer
Chem Research, Inc., Hamilton, MT). Rabbits were intra-
vectors and homologous recombination. Cells were in-
dermally injected with 0.5 to 1 mg of antigen per rabbit.
fected with the appropriate virus at an m.o.i. of 0.05 and
One month later, the rabbits were boosted subcutane-
the transfer vector transfected into the infected cells after
ously with about 0.5 mg of the same antigen. Then they
1 hr using Lipofectin (Gibco). Recombinants were plaque
were boosted in the same way a second time 1 month
purified at least three times under an agarose overlay.
later. Eleven days later, the immune serum was collected.
Three of these viruses had the spheroidin cassette in-
serted into the HA gene such that the transcription ofPreparation of a spheroidin-negative AmEPV
both genes was antiparallel. These recombinant viruses
included a vaccinia and a cowpox virus created by usingLD-652 cells in a well of a six-well plate were infected
with wild-type AmEPV at a multiplicity of infection (m.o.i.) the transfer vector, pRH261, and mycophenolic acid se-
lection (Falkner and Moss, 1988). Also containing an anti-of 5 plaque-forming units per cell in a volume of 1 ml. Two
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parallel-oriented HA and spheroidin gene cassette was
a cowpox virus recombinant created by use of transfer
vector pRH243. In this case, in the absence of the Ecogpt
gene, the recombinants were selected by use of hybrid-
ization of a spheroidin-specific PCR-produced probe
(RM95-RM93; Hall and Moyer, 1993) with monolayer rep-
lica filter lifts (Bloom et al., 1991).
Finally, a cowpox virus recombinant was created in
which the spheroidin cassette was inserted into the HA
gene such that the transcription of both genes was paral-
lel. This virus, vRH300, was made using the transfer vec-
tor pRH300, and recombinants were selected from mono-
layer replica filter lifts by using a spheroidin-specific
PCR-produced probe, RM95-RM93. In the preparation of
all four of these viruses, the presence of the spheroidin
in the HA gene was verified by PCR and/or hybridization
with a spheroidin-specific probe, as well as the presence
of cell fusion, the easily recognizable HA (0) phenotype
(Bloom et al., 1991). The spheroidin promoter region was
amplified by PCR from a vRH300 viral miniprep DNA (pre- FIG. 2. Immunoblot analysis to verify the functional integrity of the
spheroidin cassette in plasmids used to prepare recombinant vacciniapared as described by Bloom et al., 1991) and verified
and cowpox viruses. Total uninfected and infected (3 days postinfec-as intact by PCR product sequencing.
tion) LD-652 cell protein was prepared in 21 lysis buffer as described
under Materials and Methods. (A) The Coomassie blue-stained half ofRNA extraction and primer extension analysis
an SDS–PAGE gel whose other half (B) was used for a Western blot
and probed with anti-spheroidin sera. Lane M contains molecular massTo prepare total RNA from virus-infected cells, dishes
standards. The lanes are lane 1, total protein from wild-type AmEPV-
of cells were infected at an m.o.i. of 5 and harvested at infected cells (from about 1 1 104 cells); lane 2, total protein from
24 hr p.i. for mammalian cells and 48 hr p.i. for insect spheroidin-negative AmEPV-infected cells (from about 2 1 104 cells);
lane 3, total protein from uninfected LD-652 cells (from about 2 1 104cells. RNA isolation was by use of a guanidium thiocya-
cells); lanes 4 through 8, total protein from spheroidin-negative AmEPV-nate–cesium chloride procedure (Chirgwin et al., 1979).
infected cells (loaded amounts as in lane 2) which have been trans-Primer extension reactions were carried out using 32P
fected 2 hr postinfection with spheroidin cassette-containing plasmids
end-labeled primers and 40 mg of total RNA as detailed (Fig. 1): lane 4, pRH7; lane 5, pRH243; lane 6, pRH261; lane 7, pRH300;
previously (Hall and Moyer, 1991). The primers were 35- lane 8, pRH433.
base oligonucleotides which respectively began and
ended 100 and 65 bp downstream of the starting ATG.
from each. Enzymatic assays were performed using o-
For spheroidin primer extension, the primer was RM165
nitrophenyl-b-D-galactopyranoside (ONPG) as the sub-
(Hall and Moyer, 1991). The primer for the cowpox ATI
strate as described previously (Miller, 1972). Chloroform
mRNA was SM287 (CTGATTCAGAACTCAACTCATCGT-
and SDS were used instead of toluene to lyse cells.
TCCATAGTTTT). The primer for the lacZ mRNA was
Absorbance was measured at 420 nm and standardized
SM288 (AGCTGGCGAAAGGGGGATGTGCTGCAAGGC-
for a 90-min incubation time and normalized for protein
GATTA). Primer extension products were separated on
content (Bradford, 1976).
sequencing gels prepared with 8% acrylamide and 7 M
urea. Visualization was by autoradiography.
RESULTS
b-Galactosidase assays Verification of spheroidin cassette plasmids
As a prelude to our studies examining the function ofCV-1 cells in 16-mm wells (4 1 105 cells/well) were
infected at an m.o.i. of 10 with stable vaccinia recombi- the spheroidin gene regulatory elements in a vertebrate
poxvirus, various spheroidin cassettes, containing thenants which contained one of four different poxvirus pro-
moter– lacZ fusion cassettes. After 1-hr adsorption, the spheroidin promoter driving the native spheroidin open
reading frame, were inserted into the hemagglutinin geneinoculum was aspirated and the wells were rinsed twice
with phosphate-buffered saline. One milliliter of MEM of both VV and cowpox virus (CPV). The various plasmids
and transfer vectors containing the spheroidin cassettemedia with 5% FBS was added to each well and the cells
were incubated at 377. At appropriate times postinfection, were each functionally verified by transfecting them into
spheroidin-negative AmEPV-infected insect cells andthe cells were harvested by scraping into the media and
freezing at 0707 until assayed. Equal portions of each assaying the transfected cells for the ability to synthesize
spheroidin (Fig. 2). Following transfection, the proteinswell were analyzed using the equivalent of 3 1 104 cells
AID VY 8176 / 6A20$$$162 09-14-96 09:19:50 vira AP: Virology
432 HALL ET AL.
from the transfected cells were separated on polyacryl-
amide gels and visualized by either Coomassie blue
staining or immunoblot analysis. b-Galactosidase and
spheroidin are both about 116 kDa, thus accounting for
the protein band of 116 kDa in Fig. 2A in lane 2 revealed
by Coomassie blue staining of cells infected with spher-
oidin-negative AmEPV, but absent from the immunoblot
in Fig. 2B, lane 2. All plasmids were capable of express-
ing spheroidin as expected. This experiment also demon-
strates that AmEPV-infected cells can be readily trans-
fected.
Spheroidin expression in CPV recombinants
A recombinant CPV containing the spheroidin gene
was produced using the transfer vector, pRH261. We
FIG. 3. Spheroidin expression in CV-1 cells infected with achose CPV for these studies because CPV contains the
CPV:spheroidin recombinant. The virus vRH300 contains the spheroidin
highly expressed ATI gene (160 kDa), which provides a cassette inserted within the HA gene. (A) The Coomassie blue-stained
convenient internal control. Recombinant VV were also portion of an SDS–PAGE gel; the remaining duplicate portion (B) was
used for Western blotting and probing with anti-spheroidin sera. Totalprepared, and the results obtained were comparable to
infected cell protein was prepared as described under Materials andthose for CPV which we summarize here.
Methods. Lane M contains molecular weight standards. Lane 1, totalCPV recombinants were produced where the spher-
protein from LD-652 cells infected with wild-type AmEPV, and lane 2,
oidin cassette was inserted into the HA gene in both total protein from CV-1 cells infected with a CPV recombinant which
orientations relative to the HA gene promoter. Cells in- contains the spheroidin cassette inserted into the HA gene. (B) The
Western blot probed with anti-spheroidin sera.fected with the recombinant CPV which contained the
spheroidin cassette oriented in an anti-parallel fashion
to the HA promoter were found to exhibit ribosomal RNA
ATI primer (Fig. 4, lane 3) or spheroidin mRNA using thebreakdown late in infection in certain cell lines (R. Hall,
spheroidin primer, respectively (Fig. 4, lane 4), spheroidinunpublished results). This observation will not be dis-
mRNA was also found to be much less abundant thancussed further in the communication, and the remaining
ATI mRNA. Collectively, these results suggest that theexperiments focus on the recombinant cowpox virus,
spheroidin promoter is imprecise and weak, although avRH300, which contained the spheroidin cassette in-
more rapid turnover of the spheroidin mRNA cannot beserted in a parallel orientation to the flanking HA gene.
ruled out. The presence of the spheroidin gene has noSomewhat surprisingly, very low levels of spheroidin ex-
intrinsic effect on the levels of ATI mRNA (compare Fig.pression were noted compared to the ATI protein synthe-
4, lanes 3 and 5) which approximate the amounts ofsized by the recombinant virus, as visualized with Coo-
spheroidin mRNA derived from a comparable number ofmassie blue-stained gels or following immunoblot analy-
infected insect cells (Fig. 4, lane 6).sis when total protein from cells infected with vRH300
was analyzed (Figs. 3A and 3B). Indeed, spheroidin was
Spheroidin transcripts synthesized in CV-1 cells lackonly reproducibly detectable where the extracts were
5* poly(A) sequencessubjected to immunoblot analysis (Fig. 3B).
The longer-than-expected size (Fig. 4, lanes 1 and 4,Transcription of the spheroidin cassette in infected
open arrow) of the spheroidin mRNA in the vRH300-in-vertebrate cells
fected CV-1 vertebrate cells could result either from a
longer 5* poly(A) or from initiation of transcription up-In order to investigate the apparent low levels of spher-
oidin expression in cells infected with vRH300, we exam- stream from the site observed in AmEPV-infected insect
cells (Hall and Moyer, 1991).ined transcription of the spheroidin gene and steady
state mRNA levels through primer extension analysis The 5* ends of the spheroidin transcripts were se-
quenced to investigate this question. Primer extension(Fig. 4). Surprisingly, the maximum length of the primer
extension products of spheroidin mRNA from vRH300- sequencing of spheroidin mRNA derived from three
separate infected vertebrate cell lines was performedinfected CV-1 cells are longer (approximately 31 bp) (Fig.
4, lane 1, open arrow) than those of spheroidin mRNAs (Figs. 5C – 5E). As was shown in Fig. 4, the relative
level of ATI mRNA far exceeds that of spheroidin mRNAfrom wild-type AmEPV-infected insect cells (Fig. 4, lane
2, closed arrow). When equivalent amounts of total RNA (Fig. 5A). The results indicate that the longer spher-
oidin mRNA from vRH300-infected cells was not duefrom vRH300-infected cells were analyzed by primer ex-
tension for relative levels of either ATI mRNA using the to abnormally long 5* poly(A) sequences, but rather
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cells may be due in part to sequences present within
the spheroidin gene itself. Therefore we next examined
the transcription and resulting mRNA levels of the lacZ
gene fused to the spheroidin promoter. A 287-bp spher-
oidin promoter cassette containing sequences immedi-
ately upstream and including the translation-initiating
methionine codon of the spheroidin gene was fused to
the reporter gene, lacZ. This spheroidin– lacZ fusion also
eliminates any possible codon bias derived from the
spheroidin gene. As a control, a similar 288-bp ATI pro-
moter sequence, including upstream sequences and the
first coding ATG, was also fused to a lacZ cassette (ATI –
lacZ). This allowed us to compare the two promoters
under identical conditions.
When the two plasmids were transfected into vaccinia-
infected CV-1 cells, the mRNA levels were again low in
comparison to the ATI promoter (Fig. 6B). Primer exten-FIG. 4. Primer extension analysis of spheroidin and ATI mRNAs. An
sion analysis would again suggest that the spheroidinautoradiogram of 32P-labeled primer extension products of spheroidin
mRNA synthesized in vertebrate CV-1 (lane 1) or insect cells (lane 2). promoter is weak and imprecise, as the transcription
The two levels of mRNA in lanes 1 and 2 were adjusted to facilitate initiation site of the spheroidin– lacZ is far more diffuse
size comparisons of the primer extension products. Equivalent amounts compared to that for the ATI– lacZ plasmid, again an
of total RNA were also analyzed (lanes 3–6) to estimate the relative
indication of a rather imprecise transcriptional start sitequantity of ATI or spheroidin mRNA. The maximum approximate length
(compare Figs. 6A, lane 1, and 6B, lane 2). Many of theof the 5* end of the spheroidin mRNA noted in the CPV recombinant
(vRH300)-infected CV-1 cells is indicated (open arrow) as is the maxi- spheroidin– lacZ transcripts again appear longer than ex-
mum approximate length of the spheroidin mRNA in analyzed RNA pected. On the other hand, when the ATI– lacZ cassette
from wild-type AmEPV-infected LD-652 cells (closed arrow). RNA from was transfected into entomopoxvirus-infected insect
CV-1 cells infected with the spheroidin cassette CPV recombinant
cells, transcription was normal with the expected tran-(vRH300) was analyzed with either the ATI primer (lane 3) or the spher-
scription site and with a 5* poly(A) tract on the mRNAoidin primer (lane 4). Lanes 5 and 6 represent primer extension controls
in which lane 5 contains nonrecombinant wild-type CPV primer exten- (Fig. 6C).
sion products (ATI primer), and lane 6 shows the products obtained
from mRNA derived from wild-type AmEPV-infected insect cells using b-Galactosidase production in promoter– lacZ-
the spheroidin primer.
containing recombinants
The promoter– lacZ cassettes described in Fig. 7 were
from initiation of transcription upstream of the initiation inserted within the TK gene of vaccinia to produce stable
site normally utilized in infected insect cells (Figs. 5C – recombinants so that we might quantitate b-galactosi-
5E). No discrete poly(A) sequence was evident in the dase produced by each construct. We compared expres-
spheroidin mRNA derived from the infected vertebrate sion not only to that from the ATI promoter, but also from
cells. The sequence observed 5* to the normal starting the well-characterized p11 and p7.5 promoters. Despite
ATG was in accord with the published spheroidin up- the unusual transcription pattern noted for the spher-
stream sequence consistent with ‘‘readthrough’’ from oidin– lacZ fusion, some b-galactosidase is produced,
transcripts originating upstream of the expected tran- although the levels are less than that from any of the
scription site. Typical spheroidin mRNAs from AmEPV- vertebrate poxvirus promoters tested (Fig. 7). It is clear
infected insect cells (Fig. 5B) and ATI mRNAs from that based on the ability to synthesize active b-galactosi-
wild-type cowpox virus-infected vertebrate cells (Fig. dase the spheroidin promoter again behaves as a very
5F ) both show 5* poly(A) beginning at one of the As of weak promoter in vertebrate systems.
the TAAATG sequence at the starting ATG typical of
late poxvirus promoters. This unusual pattern of spher- DISCUSSION
oidin transcription was seen in three different vRH300-
Despite the fact that the spheroidin protein is the mostinfected vertebrate cell lines (Figs. 5C – 5E).
abundant protein found within AmEPV-infected insect
cells, the data presented are most consistent with theTranscription of spheroidin promoter lacZ fusions
interpretation that the spheroidin promoter in vertebrate
cells functions poorly (if at all) as a very weak late pro-The experiments thus far have examined the behavior
of the spheroidin promoter within the context of the moter with a rather imprecise transcriptional start site in
CPV- or VV-infected vertebrate cells. This is in strikingspheroidin gene. It is possible that the unexpected be-
havior of the spheroidin promoter in infected vertebrate contrast to what has been observed for the spheroidin
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FIG. 5. Primer extension sequencing analyses. (A) The relative quantities and mean sizes of primer extension products from RNA isolated from
the CPV spheroidin cassette-containing recombinant (vRH300)-infected CV-1 cells using either the ATI primer (lane 1, closed arrow) or the spheroidin
primer (lane 2, open arrow). (B) The sequence derived from total RNA isolated from wild-type AmEPV-infected LD-652 cells using the spheroidin
mRNA primer. (C–E) Sequence derived from total RNA from vRH300-infected RK-13 cells (C), BSC40 cells (D), or CV-1 cells (E) using the spheroidin
primer. (F) Primer extension products from total RNA from wild-type CPV-infected CV-1 cells, using the ATI primer.
gene within the native context of AmEPV-infected insect served within infected insect cells (Hall and Moyer, 1991).
The sequence at this site GGAC*TTTTTATTTTTT (* pre-cells. Primer extension analysis indicates that this low
level of transcription originates approximately 31 bp up- cedes the 31st upstream base) is not the typical late
promoter sequence (TAAAGT) utilized for spheroidinstream of the start site for spheroidin transcription ob-
transcription in the insect environment. In analyzing ex-
pression of the intact, native spheroidin gene within ver-
tebrate cells infected with VV, it is important to recognize
both that any possible regulatory elements downstream
of the known transcription start site would also be in-
cluded and that turnover of spheroidin mRNA in verte-
brate cells might be much more rapid than the ATI
mRNA. Typically, poxvirus promoters retain their relative
strengths when removed from native context and fused
FIG. 6. Primer extension analyses of promoter– lacZ constructs. Re-
sults from transfections into vaccinia-infected CV-1 cells are shown in
A and B (darker exposure of A). The lanes are lane 1, primer extension
products from total RNA from cells transfected with the lacZ cassette
regulated by the ATI promoter (closed arrow); lane 2, primer extension
products from cells transfected with the lacZ cassette regulated by the FIG. 7. Time course of b-galactosidase production in stable vaccinia
recombinants containing various promoter– lacZ constructs. The pro-spheroidin promoter (open arrow). The amounts of RNA analyzed in A
and B are identical and differ only in exposure time on film. (C) Primer moters included p11 (l) from vaccinia, ATI (l) from the cowpox A-
type inclusion protein gene, p7.5 (m) from vaccinia, and spheroidin (j)extension sequencing of total RNA from AmEPV-infected insect cells
which were transfected with plasmid DNA containing the lacZ cassette from the AmEPV spheroidin gene. Each promoter was about 280 bp in
length except for the p11 promoter which was 101 bp. b-Galactosidasedriven by the ATI promoter. Infected vertebrate cells or insect cells
were transfected at 1 and 2 hr p.i., respectively, and total RNA was assays were performed using an ONPG procedure as explained under
Materials and Methods and corrected for the amount of protein.harvested at 24 and 48 hr p.i., respectively.
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to reporter genes such as lacZ (Puckett and Moss, 1983; 03, 08, and 09. A T residue is substituted for an A or
C at position 07. Single-base substitutions at the above-Mackett et al., 1984). However, spheroidin promoter ac-
tivity remained poor whether transcription was from the listed locations would by themselves not necessarily be
expected to result in a drastic effect on promoter utiliza-intact spheroidin gene or whether the promoter was used
in context of a lacZ fusion. Equally surprising was the tion (Davison and Moss, 1989). However, collectively,
these differences might lead to the effects observed here.failure to readily detect the 5* poly(A) sequences in tran-
scripts regulated by the spheroidin promoter. The 5* po- It is also worth considering that the spheroidin gene
may be specialized and unique, even in the insect sys-ly(A) sequences, a feature typical of many intermediate
and late transcripts (Schwer and Stunnenberg, 1988), tem. In AmEPV-infected insect cells, spheroidin synthesis
first begins at about 15 hr postinfection, typical of latepresumably result from ‘‘slippage’’ during the initiation of
intermediate/late gene transcription. The lack of 5* po- proteins, but continues to be produced until at least 72
hr postinfection, long after expression of other AmEPVly(A) makes even the assignment of these transcripts
to ‘‘early,’’ ‘‘intermediate,’’ or ‘‘late’’ transcription classes proteins has ceased (Winter et al., 1995). Therefore, the
spheroidin gene may be unusual, even among AmEPVdifficult. The unexpected transcription start site(s) may
also be related to apparent lack of 5* poly(A) addition. genes, and would then be similar to the polyhedrin pro-
tein of baculoviruses. Answers to these questions awaitAn implication of the poor and imprecise utilization of
the spheroidin promoter in VV-infected vertebrate cells further analysis of the spheroidin gene promoter and
other AmEPV promoters in vertebrate cells as well asis that the regulatory signals which govern poxvirus gene
expression may not be strictly conserved among the a thorough analysis of a variety of vertebrate poxvirus
promoters within the insect environment.more divergent members of the poxvirus family.
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